Metabolism of amyloid-β peptide and Alzheimer's disease

Pharmacology and Therapeutics

Volumn 108, Issue 2, 2005, Pages 129-148

  Iwata, Nobuhisa ^a   Higuchi, Makoto ^a   Saido, Takaomi C ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Aging; Alzheimer's disease; Amyloid peptide; Neprilysin; Somatostatin

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; EFLA 85942; ENDOTHELIN CONVERTING ENZYME; EPICATECHIN; EPIGALLOCATECHIN GALLATE; G PROTEIN COUPLED RECEPTOR; GREEN TEA EXTRACT; LENTIVIRUS VECTOR; MEMBRANE METALLOENDOPEPTIDASE; PARVOVIRUS VECTOR; PRESENILIN 1; QUERCETIN; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

AGE; AGING; ALZHEIMER DISEASE; BRAIN CORTEX; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DOWN REGULATION; ENZYME ACTIVITY; FAMILIAL DISEASE; GENE DISRUPTION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMAN; NERVE CELL; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY; UPREGULATION; VASCULAR AMYLOIDOSIS; VIRAL GENE DELIVERY SYSTEM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN CHEMISTRY; GENE THERAPY; HUMANS; NEPRILYSIN;

EID: 27344441173     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.03.010     Document Type: Review

References (171)

1. H. Akiyama, H. Kondo, K. Ikeda, M. Kato, and P.L. McGeer Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid β-protein (Aβ) deposition Brain Res 902 2001 277 281
2. J. Apelt, K. Ach, and R. Schliebs Aging-related down-regulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaques Neurosci Lett 339 2003 183 186
3. S.A. Back, and C. Gorenstein Histochemical visualization of neutral endopeptidase-24.11 (enkephalinase) activity in rat brain: cellular localization and codistribution with enkephalins in the globus pallidus J Neurosci 9 1989 4439 4455
4. J.R. Backstrom, G.P. Lim, M.J. Cullen, and Z.A. Tokes Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40) J Neurosci 16 1996 7910 7919
5. S.J. Bae, Y. Matsunaga, M. Takenaka, Y. Tanaka, Y. Hamazaki, and K. Shimizu Substance P induced preprotachykinin A mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts Int Arch Allergy Immunol 127 2002 316 321
6. F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, and H. Grajeda Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat Med 6 2000 916 919
7. K. Barnes, A.J. Turner, and A.J. Kenny Electronmicroscopic immunocytochemistry of pig brain shows that endopeptidase-24.11 is localized in neuronal membranes Neurosci Lett 94 1988 64 69
8. K. Barnes, A.J. Turner, and A.J. Kenny Membrane localization of endopeptidase-24.11 and peptidyl dipeptidase A (angiotensin converting enzyme) in the pig brain: a study using subcellular fractionation and electron microscopic immunocytochemistry J Neurochem 58 1992 2088 2096
9. K. Barnes, S. Doherty, and A.J. Turner Endopeptidase-24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus J Neurochem 64 1995 1826 1832
10. M.F. Beal, M.F. Mazurek, G.K. Chattha, C.N. Svendsen, E.D. Bird, and J.B. Martin Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease Ann Neurol 20 1986 282 288
11. L.M. Bierer, V. Haroutunian, S. Gabriel, P.J. Knott, L.S. Carlin, and D.P. Purohit Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits J Neurochem 64 1995 749 760
12. G. Bissette, G.P. Reynolds, C.D. Kilts, E. Widerlov, and C.B. Nemeroff Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations JAMA 254 1985 3067 3069
13. G. Bissette, L. Cook, W. Smith, K.C. Dole, B. Crain, and C.B. Nemeroff Regional neuropeptide pathology in Alzheimer's disease: corticotropin-releasing factor and somatostatin J Alzheimers Dis 1 1998 91 105
14. D.R. Borchelt, G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, and T. Ratovitsky Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo Neuron 17 1996 1005 1013
15. D.R. Borchelt, T. Ratovitski, J. van Lare, M.K. Lee, V. Gonzales, and N. Jenkins Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins Neuron 19 1997 939 945
16. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol (Berl) 82 1991 239 259
17. J.F. Bruno, Y. Xu, J. Song, and M. Berelowitz Molecular cloning and functional expression of a brain-specific somatostatin receptor Proc Natl Acad Sci U S A 89 1992 11151 11155
18. M. Buttini, G.Q. Yu, K. Shockley, Y. Huang, B. Jones, and E. Masliah Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid β peptides but not on plaque formation J Neurosci 22 2002 10539 10548
19. J.D. Buxbaum, G. Thinakaran, V. Koliatsos, J. O'Callahan, H.H. Slunt, and D.L. Price Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path J Neurosci 18 1998 9629 9637
20. K.M. Carvalho, M.S. Franca, G.C. Camarao, and A.F. Ruchon A new brain metalloendopeptidase which degrades the Alzheimer β-amyloid 1-40 peptide producing soluble fragments without neurotoxic effects Braz J Med Biol Res 30 1997 1153 1156
21. V. Chan-Palay Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia J Comp Neurol 273 1988 543 557
22. P.F. Chapman, G.L. White, M.W. Jones, D. Cooper-Blacketer, V.J. Marshall, and M. Irizarry Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice Nat Neurosci 2 1999 271 276
23. V. Chesneau, K. Vekrellis, M.R. Rosner, and D.J. Selkoe Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization Biochem J 351 2000 509 516
24. M.A. Chishti, D.S. Yang, C. Janus, A.L. Phinney, P. Horne, and J. Pearson Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J Biol Chem 276 2001 21562 21570
25. J. Clarimón, F.J. Muñoz, M. Boada, L. Tàrraga, J. Sunyer, and J. Bertranpetit Possible increased risk for Alzheimer's disease associated with neprilysin gene J Neural Transm 110 2003 651 657
26. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, and D.J. Selkoe Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function Nat Neurosci 8 2005 79 84
27. H.A. Crystal, and P. Davies Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type J Neurochem 38 1982 1781 1784
28. Z. Csaba, and P. Dournaud Cellular biology of somatostatin receptors Neuropeptides 35 2001 1 23
29. L. D'Adamio, M.A. Shipp, E.L. Masteller, and E.L. Reinherz Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5′ untranslated regions Proc Natl Acad Sci U S A 86 1989 7103 7107
30. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403
31. P. Davies, R. Katzman, and R.D. Terry Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa Nature 288 1980 279 280
32. F. de Bree Neuropeptides in the therapy of Alzheimer's disease Drug News Perspect 14 2001 151 157
33. B. De Strooper Aph-1, Pen-2, and nicastrin with presenilin generate an active γ-secretase complex Neuron 38 2003 9 12
34. I. Dolev, and D.M. Michaelson A nontransgenic mouse model shows inducible amyloid-β (Aβ) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade Proc Natl Acad Sci U S A 101 2004 13909 13914
35. W.C. Duckworth, R.G. Bennett, and F.G. Hamel Insulin degradation: progress and potential Endocr Rev 19 1998 608 624
36. K. Duff, C. Eckman, C. Zehr, X. Yu, C.M. Prada, and J. Perez-tur Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 Nature 383 1996 710 713
37. A. Eckert, G. Segond von Banchet, S. Sopper, and M. Petersen Spatio-temporal pattern of induction of bradykinin receptors and inflammation in rat dorsal root ganglia after unilateral nerve ligation Pain 83 1999 487 497
38. E.A. Eckman, D.K. Reed, and C.B. Eckman Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme J Biol Chem 276 2001 24540 24548
39. E.A. Eckman, M. Watson, L. Marlow, K. Sambamurti, and C.B. Eckman Alzheimer's disease β-amyloid peptide is increased in mice deficient in endothelin-converting enzyme J Biol Chem 278 2003 2081 2084
40. D. Edbauer, M. Willem, S. Lammich, H. Steiner, and C. Haass Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD) J Biol Chem 277 2002 13389 13393
41. N. Ertekin-Taner, J. Ronald, L. Feuk, J. Prince, M. Tucker, and L. Younkin Elevated amyloid β protein (Aβ42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene Hum Mol Genet 14 2005 447 460
42. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci U S A 100 2003 4162 4167
43. W. Farris, S. Mansourian, M.A. Leissring, E.A. Eckman, L. Bertram, and C.B. Eckman Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid β-protein Am J Pathol 164 2004 1425 1434
44. M.S. Forman, J.Q. Trojanowski, and V.M. Lee Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs Nat Med 10 2004 1055 1063
45. T.F. Freund, and G. Buzsaki Interneurons of the hippocampus Hippocampus 6 1996 347 470
46. K. Fujiyoshi, H. Suga, K. Okamoto, S. Nakamura, and M. Kameyama Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia J Neurol Neurosurg Psychiatry 50 1987 929 932
47. S. Fukami, K. Watanabe, N. Iwata, J. Haraoka, B. Lu, and N.P. Gerard Aβ-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Aβ pathology Neurosci Res 43 2002 39 56
48. H. Funato, M. Yoshimura, K. Kusui, A. Tamaoka, K. Ishikawa, and N. Ohkoshi Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease Am J Pathol 152 1998 1633 1640
49. S.M. Gabriel, M. Davidson, V. Haroutunian, P. Powchik, L.M. Bierer, and D.P. Purohit Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex Biol Psychiatry 39 1996 82 91
50. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, and C. Blackwell Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein Nature 373 1995 523 527
51. A. Garcia-Jimenez, J. Fastbom, B. Winbland, and R.F. Cowburn G-protein regulation of signal transduction in Alzheimer's disease Brain Aging 2 2002 7 15
52. T. Gómez-Isla, J.L. Price, D.W. McKeel Jr., J.C. Morris, J.H. Growdon, and B.T. Hyman Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease J Neurosci 16 1996 4491 4500
53. E. Hama, K. Shirotani, H. Masumoto, Y. Sekine-Aizawa, H. Aizawa, and T.C. Saido Clearance of extracellular and cell-associated amyloid β peptide through viral expression of neprilysin in primary neurons J Biochem (Tokyo) 130 2001 721 726
54. E. Hama, K. Shirotani, N. Iwata, and T.C. Saido Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid β peptide clearance in primary neurons J Biol Chem 279 2004 30259 30264
55. H. Hamazaki Cathepsin D is involved in the clearance of Alzheimer's β-amyloid protein FEBS Lett 396 1996 139 142
56. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
57. D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, and P.M. Vassilev Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J Neurosci 19 1999 8876 8884
58. M. Hayashi, A. Yamashita, and K. Shimizu Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNAs during aging Brain Res 749 1997 283 289
59. S. Helisalmi, M. Hiltunen, S. Vepsäläinen, S. Iivonen, A. Mannermaa, and M. Lehtovirta Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients J Neurol Neurosurg Psychiatry 75 2004 1746 1748
60. D.B. Henken, W.P. Battisti, M.F. Chesselet, M. Murray, and A. Tessler Expression of β-preprotachykinin mRNA and tachykinins in rat dorsal root ganglion cells following peripheral or central axotomy Neuroscience 39 1990 733 742
61. 1H-MRI detection of amyloid-β plaques in vivo Nat Neurosci 8 2005 527 533
62. M. Hoshi, M. Sato, S. Matsumoto, A. Noguchi, K. Yasutake, and N. Yoshida Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β Proc Natl Acad Sci U S A 100 2003 6370 6375
63. S. Howell, A.M. Caswell, A.J. Kenny, and A.J. Turner Membrane peptidases on human osteoblast-like cells in culture: hydrolysis of calcitonin and hormonal regulation of endopeptidase-24.11 Biochem J 290 1993 159 164
64. S. Howell, J. Nalbantoglu, and P. Crine Neutral endopeptidase can hydrolyze β-amyloid(1-40) but shows no effect on β-amyloid precursor protein metabolism Peptides 16 1995 647 652
65. A.Y. Hsia, E. Masliah, L. McConlogue, G.Q. Yu, G. Tatsuno, and K. Hu Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc Natl Acad Sci U S A 96 1999 3228 3233
66. J. Hu, A. Igarashi, M. Kamata, and H. Nakagawa Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ); retards Aβ aggregation, deposition, fibril formation; and inhibits cytotoxicity J Biol Chem 276 2001 47863 47868
67. C. Ichai, N. Chevallier, P. Delaere, P. Dournaud, J. Epelbaum, and J.J. Hauw Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease J Neurochem 62 1994 645 655
68. H. Imataka, K. Nakayama, K. Yasumoto, A. Mizuno, Y. Fujii-Kuriyama, and M. Hayami Cell-specific translational control of transcription factor BTEB expression. The role of an upstream AUG in the 5′-untranslated region J Biol Chem 269 1994 20668 20673
69. M.C. Irizarry, F. Soriano, M. McNamara, K.J. Page, D. Schenk, and D. Games Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse J Neurosci 17 1997 7053 7059
70. F. Ishimaru, and M.A. Shipp Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements Blood 85 1995 3199 3207
71. F. Ishimaru, B. Mari, and M.A. Shipp The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms Blood 89 1997 4136 4145
72. N. Iwata, S. Tsubuki, E. Hama, Y. Takaki, K. Shirotani, and T.C. Saido Reply to: "Clearance of Amyloid β-peptide from Brain: Transport or Metabolism?" Nat Med 6 2000 718 719
73. 1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition Nat Med 6 2000 143 150
74. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, and N.P. Gerard Metabolic regulation of brain Aβ by neprilysin Science 292 2001 1550 1552
75. N. Iwata, Y. Takaki, S. Fukami, S. Tsubuki, and T.C. Saido Region-specific reduction of Aβ-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging J Neurosci Res 70 2002 493 500
76. N. Iwata, H. Mizukami, K. Shirotani, Y. Takaki, S. Muramatsu, and B. Lu Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain J Neurosci 24 2004 991 998
77. Y. Ji, B. Permanne, E.M. Sigurdsson, D.M. Holtzman, and T. Wisniewski Amyloid β40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice J Alzheimers Dis 3 2001 23 30
78. G.D. Johnson, T. Stevenson, and K. Ahn Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin J Biol Chem 274 1999 4053 4058
79. K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, and R. Barbour Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease Proc Natl Acad Sci U S A 94 1997 1550 1555
80. D.D. Joshi, A. Dang, P. Yadav, J. Qian, P.S. Bandari, and K. Chen Negative feedback on the effect of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study Blood 98 2001 2697 2706
81. H. Kanemitsu, T. Tomiyama, and H. Mori Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form Neurosci Lett 350 2003 113 116
82. M. Koistinaho, S. Lin, X. Wu, M. Esterman, D. Koger, and J. Hanson Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides Nat Med 10 2004 719 726
83. H. Kokubo, R. Kayed, C.G. Glabe, and H. Yamaguchi Soluble Aβ oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain Brain Res 103 2005 222 228
84. E.H. Koo, and R. Kopan Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration Nat Med 10 Suppl. 2004 S26 S33
85. Y.M. Kuo, M.R. Emmerling, C. Vigo-Pelfrey, T.C. Kasunic, J.B. Kirkpatrick, and G.H. Murdoch Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains J Biol Chem 271 1996 4077 4081
86. I.V. Kurochkin, and S. Goto Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme FEBS Lett 345 1994 33 37
87. M.H. Lafrance, C. Vezina, Q. Wang, G. Boileau, P. Crine, and G. Lemay Role of glycosylation in transport and enzymic activity of neutral endopeptidase-24.11 Biochem J 302 1994 451 454
88. 1-42 are potent central nervous system neurotoxins Proc Natl Acad Sci U S A 95 1998 6448 6453
89. O. Lazarov, M. Lee, D.A. Peterson, and S.S. Sisodia Evidence that synaptically released β-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice J Neurosci 22 2002 9785 9793
90. M.A. Leissring, W. Farris, A.Y. Chang, D.M. Walsh, X. Wu, and X. Sun Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 40 2003 1087 1093
91. C. Li, and L.B. Hersh Characterization of the promoter region of the rat neprilysin gene Arch Biochem Biophys 358 1998 189 195
92. C. Li, R.M. Booze, and L.B. Hersh Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs J Biol Chem 270 1995 5723 5728
93. L. Lilius, C. Forsell, K. Axelman, B. Winblad, C. Graff, and L. Tjernberg No association between polymorphisms in the neprilysin promoter region and Swedish Alzheimer's disease patients Neurosci Lett 337 2003 111 113
94. B. Lu, M. Figini, C. Emanueli, P. Geppetti, E.F. Grady, and N.P. Gerard The control of microvascular permeability and blood pressure by neutral endopeptidase Nat Med 3 1997 904 907
95. T. Lu, Y. Pan, S.Y. Kao, C. Li, I. Kohane, and J. Chan Gene regulation and DNA damage in the ageing human brain Nature 429 2004 883 891
96. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, and L. Sue Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease Am J Pathol 155 1999 853 862
97. R.A. Marr, E. Rockenstein, A. Mukherjee, M.S. Kindy, L.B. Hersh, and F.H. Gage Neprilysin gene transfer reduces human amyloid pathology in transgenic mice J Neurosci 23 2003 1992 1996
98. R. Matsas, A.J. Kenny, and A.J. Turner The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11 Biochem J 223 1984 433 440
99. J.R. McDermott, and A.M. Gibson Degradation of Alzheimer's β-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme Neurochem Res 22 1997 49 56
100. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, and K. Beyreuther Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann Neurol 46 1999 860 866
101. M.F. Melzig, and F. Escher Induction of neutral endopeptidase and angiotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol Pharmazie 57 2002 556 558
102. M.F. Melzig, and M. Janka Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract Phytomedicine 10 2003 494 498
103. G. Miesenbock, D.A. De Angelis, and J.E. Rothman Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins Nature 394 1998 192 195
104. B.C. Miller, E.A. Eckman, K. Sambamurti, N. Dobbs, K.M. Chow, and C.B. Eckman Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo Proc Natl Acad Sci U S A 100 2003 6221 6226
105. M.H. Mohajeri, M.A. Wollmer, and R.M. Nitsch Aβ42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo J Biol Chem 277 2002 35460 35465
106. M.H. Mohajeri, K. Kuehnle, H. Li, R. Poirier, J. Tracy, and R.M. Nitsch Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease FEBS Lett 562 2004 16 21
107. L.N. Moller, C.E. Stidsen, B. Hartmann, and J.J. Holst Somatostatin receptors Biochim Biophys Acta 1616 2003 1 84
108. L. Morelli, R. Llovera, S.A. Gonzalez, J.L. Affranchino, F. Prelli, and B. Frangione Differential degradation of amyloid β genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme J Biol Chem 278 2003 23221 23226
109. J.H. Morrison, and P.R. Hof Life and death of neurons in the aging brain Science 278 1997 412 419
110. 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J Neurosci 20 2000 4050 4058
111. Y. Nakano, G. Kondoh, T. Kudo, K. Imaizumi, M. Kato, and J.I. Miyazaki Accumulation of murine amyloidβ42 in a gene-dosage-dependent manner in PS1 'knock-in' mice Eur J Neurosci 11 1999 2577 2581
112. J.A. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham, and R.O. Weller Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report Nat Med 9 2003 448 452
113. G. O'Cuinn, B. O'Connor, L. Gilmartin, and M. Smyth Neuropeptide inactivation by peptidase G. O'Cuinn Metabolism of Brain Peptides 1995 CRC Press New York 99 157
114. M. Oda, H. Morino, H. Maruyama, H. Terasawa, Y. Izumi, and T. Torii Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease Neurosci Lett 320 2002 105 107
115. C. Oefner, A. D'Arcy, M. Hennig, F.K. Winkler, and G.E. Dale Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon J Mol Biol 296 2000 341 349
116. R.C. Petersen, R. Doody, A. Kurz, R.C. Mohs, J.C. Morris, and P.V. Rabins Current concepts in mild cognitive impairment Arch Neurol 58 2001 1985 1992
117. A.L. Phinney, T. Deller, M. Stalder, M.E. Calhoun, M. Frotscher, and B. Sommer Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice J Neurosci 19 1999 8552 8559
118. H. Pollard, M.L. Bouthenet, J. Moreau, E. Souil, P. Verroust, and P. Ronco Detailed immunoautoradiographic mapping of enkephalinase (EC 3.4.24.11) in rat central nervous system: comparison with enkephalins and substance P Neuroscience 30 1989 339 376
119. D.L. Price, S.S. Sisodia, P.C. Wong, and D.R. Borchelt Alzheimer's disease: the value of transgenic and gene targeted models Neurosci News 3 2000 71 81
120. W.Q. Qiu, D.M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, and M.B. Podlisny Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation J Biol Chem 273 1998 32730 32738
121. B.P. Roques, F. Noble, V. Dauge, M.C. Fournie-Zaluski, and A. Beaumont Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology Pharmacol Rev 45 1993 87 146
122. J.T. Rogers, L.M. Leiter, J. McPhee, C.M. Cahill, S.S. Zhan, and H. Potter Translation of the Alzheimer's amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences J Biol Chem 274 1999 6421 6431
123. M. Rossor, J. Fahrenkrug, P. Emson, C. Mountjoy, L. Iversen, and M. Roth Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide Brain Res 201 1980 249 253
124. M.N. Rossor, J.F. Rehfeld, P.C. Emson, C.Q. Mountjoy, M. Roth, and L.L. Iversen Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type Life Sci 29 1981 405 410
125. T.C. Saido Overview-Aβ metabolism: from Alzheimer research to brain aging control T.C. Saido Aβ Metabolism and Alzheimer's Disease, Ch. 1 2003 Landes Bioscience Texas 1 16
126. T.C. Saido, and H. Nakahara Proteolytic degradation of Aβ by neprilysin and other peptidases T.C. Saido Aβ Metabolism and Alzheimer's Disease, Ch. 6 2003 Landes Bioscience Texas 61 80
127. T. Saito, Y. Takaki, N. Iwata, J. Trojanowski, and T.C. Saido Alzheimer's disease, neuropeptides, neuropeptidase, and amyloid-β peptide metabolism Sci Aging Knowledge Environ 2003 3 2003 E1
128. 42, via modulation of proteolytic degradation Nat Med 11 2005 434 439
129. A. Sakai, H. Ujike, K. Nakata, Y. Takehisa, T. Imamura, and N. Uchida Association of the neprilysin gene with susceptibility to late-onset Alzheimer's disease Dement Geriatr Cogn Disord 17 2004 164 169
130. C. Sakurada, S. Sakurada, T. Orito, K. Tan-No, and T. Sakurada Degradation of nociceptin (orphanin FQ) by mouse spinal cord synaptic membranes is triggered by endopeptidase-24.11: an in vitro and in vivo study Biochem Pharmacol 64 2002 1293 1303
131. A. Saria, K.F. Hauser, H.H. Traurig, C.S. Turbek, L. Hersh, and C. Gerard Opioid-related changes in nociceptive threshold and in tissue levels of enkephalins after target disruption of the gene for neutral endopeptidase (EC 3.4.24.11) in mice Neurosci Lett 234 1997 27 30
132. S.M. Saporito-Irwin, and W.E. Van Nostrand Coagulation factor XIa cleaves the RHDS sequence and abolishes the cell adhesive properties of the amyloid β-protein J Biol Chem 270 1995 26265 26269
133. 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques Eur J Med Chem 39 2004 573 578
134. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, and N. Suzuki Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat Med 2 1996 864 870
135. M. Schindler, P.P. Humphrey, and P.C. Emson Somatostatin receptors in the central nervous system Prog Neurobiol 50 1996 9 47
136. A. Schmitz, A. Schneider, M.P. Kummer, and V. Herzog Endoplasmic reticulum-localized amyloid β-peptide is degraded in the cytosol by two distinct degradation pathways Endoplasmic Traffic 5 2004 89 101
137. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol Rev 81 2001 741 766
138. D.J. Selkoe Clearing the brain's amyloid cobwebs Neuron 32 2001 177 180
139. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
140. P. Seubert, T. Oltersdorf, M.G. Lee, R. Barbour, C. Blomquist, and D.L. Davis Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide Nature 361 1993 260 263
141. N. Sezaki, F. Ishimaru, T. Tabayashi, I. Kataoka, K. Nakase, and K. Fujii The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5′-untranslated region Br J Haematol 123 2003 177 183
142. J.G. Sheng, D.L. Price, and V.E. Koliatsos Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Aβ amyloidosis J Neurosci 22 2002 9794 9799
143. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, and M. Ikeda Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
144. K. Shirotani, S. Tsubuki, N. Iwata, Y. Takaki, W. Harigaya, and K. Maruyama Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases J Biol Chem 276 2001 21895 21901
145. C. Shukla, and L.R. Bridges Tau, β-amyloid and β-amyloid precursor protein distribution in the entorhinal-hippocampal alvear and perforant pathways in the Alzheimer's brain Neurosci Lett 303 2001 193 197
146. N. Sodeyama, H. Mizusawa, M. Yamada, Y. Itoh, E. Otomo, and M. Matsushita Lack of association of neprilysin polymorphism with Alzheimer's disease and Alzheimer's disease-type neuropathological changes J Neurol Neurosurg Psychiatry 71 2001 817 818
147. A.D. Spier, and L. de Lecea Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions Brain Res Rev 33 2000 228 241
148. C. Sturchler-Pierrat, D. Abramowski, M. Duke, K.H. Wiederhold, C. Mistl, and S. Rothacher Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proc Natl Acad Sci U S A 94 1997 13287 13292
149. S. Sung, Y. Yao, K. Uryu, H. Yang, V.M. Lee, and J.Q. Trojanowski Early vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease FASEB J 18 2004 323 325
150. N. Suzuki, T.T. Cheung, X.D. Cai, A. Odaka, L. Otvos Jr., and C. Eckman An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants Science 264 1994 1336 1340
151. C.I. Sze, J.C. Troncoso, C. Kawas, P. Mouton, D.L. Price, and L.J. Martin Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease J Neuropathol Exp Neurol 56 1997 933 944
152. Y. Takaki, N. Iwata, S. Tsubuki, S. Taniguchi, S. Toyoshima, and B. Lu Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid β peptide in the brain J Biochem (Tokyo) 128 2000 897 902
153. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, and R. Hill Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
154. S. Tsubuki, Y. Takaki, and T.C. Saido Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation Lancet 361 2003 1957 1958
155. H.M. Tucker, J. Simpson, M. Kihiko-Ehmann, L.H. Younkin, J.P. McGillis, and S.G. Younkin Plasmin deficiency does not alter endogenous murine amyloid β levels in mice Neurosci Lett 368 2004 285 289
156. A.J. Turner Neprilysin A.J. Barrett N.D. Rawlings J.F. Woessner Handbook of Proteolytic Enzymes, Second edition, vol. 1, Ch. 108 2004 Academic Press London 419 426
157. J.A.P. van de Nes, D. Sandmann-Keil, and H. Braak Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes Acta Neuropathol 104 2002 351 356
158. W.E. Van Nostrand, and M. Porter Plasmin cleavage of the amyloid β-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity Biochemistry 38 1999 11570 11576
159. K. Vekrellis, Z. Ye, W.Q. Qiu, D. Walsh, D. Hartley, and V. Chesneau Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme J Neurosci 20 2000 1657 1665
160. G. Waksman, E. Hamel, P. Delay-Goyet, and B.P. Roques Neuronal localization of the neutral endopeptidase 'enkephalinase' in rat brain revealed by lesions and autoradiography EMBO J 5 1986 3163 3166
161. G. Waksman, E. Hamel, M.C. Fournie-Zaluski, and B.P. Roques Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain Proc Natl Acad Sci U S A 83 1986 1523 1527
162. D.M. Walsh, D.M. Hartley, Y. Kusumoto, Y. Fezoui, M.M. Condron, and A. Lomakin Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates J Biol Chem 274 1999 25945 25952
163. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, and M.S. Wolfe Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
164. T.L. Wang, H. Chang, C.R. Hung, and Y.Z. Tseng Attenuation of neutrophil and endothelial activation by intravenous morphine in patients with acute myocardial infarction Am J Cardiol 80 1997 532 1535
165. H.W. Wang, J.F. Pasternak, H. Kuo, H. Ristic, M.P. Lambert, and B. Chromy Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus Brain Res 924 2002 133 140
166. D.S. Wang, N. Iwata, E. Hama, T.C. Saido, and D.W. Dickson Oxidized neprilysin in aging and Alzheimer's disease brains Biochem Biophys Res Commun 310 2003 238 243
167. M.P. Witter, and D.G. Amaral Hippocampal formation G. Paxinos The Rat Nervous System, Ch. 21 Third ed. 2004 Academic Press San Diego 635 704
168. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, and F. Yan Adult mouse astrocytes degrade amyloid-β in vitro and in situ Nat Med 9 2003 453 457
169. T. Yamada, K. Miyazaki, N. Koshikawa, M. Takahashi, H. Akatsu, and T. Yamamoto Selective localization of gelatinase A, an enzyme degrading β-amyloid protein, in white matter microglia and in Schwann cells Acta Neuropathol 89 1995 199 203
170. K. Yasojima, H. Akiyama, E.G. McGeer, and P.L. McGeer Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide Neurosci Lett 297 2001 97 100
171. K. Yasojima, E.G. McGeer, and P.L. McGeer Relationship between β amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain Brain Res 919 2001 115 121